Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children’s Oncology GroupKristina K. Hardy, Naomi Winick, Meenakshi Devidas et al.|Journal of Clinical Oncology|2017Cited by 57
Neurocognitive function of children treated for high-risk B-acute lymphoblastic leukemia (HR-ALL) randomized to Capizzi (CMTX) versus high-dose methotrexate (HDMTX): A report from the Children’s Oncology Group (COG).Naomi Winick, Robert B. Noll, Leanne Embry et al.|Journal of Clinical Oncology|2015Cited by 0